# US 2016/0251386 A1 · Lipid Co-factor Essential for Cell Density Signaling

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0251386 A1
- Document ID: US20160251386A1
- Status: Published application
- Kind: A1
- Application number: 15/137,448
- Filed: 2016-04-25
- Published: 2016-09-01
- Earliest claimed: 2013-10-28
- Inventors: Richard I. Schwarz
- Web page: https://patentgrep.com/patent/US20160251386A1

## CPC

- C07F 9/572: Five-membered rings
- B01D 61/145: {Ultrafiltration}
- B01D 61/16: Feed pretreatment
- C07K 14/465: from birds
- C07K 14/47: from mammals
- C07K 14/4705: {stimulating, promoting or activating activity}
- C07K 16/18: against material from animals or humans
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- B01D: SEPARATION (separating solids from solids by wet methods B03B, B03D; by pneumatic jigs or tables B03B; by other dry methods B07; magnetic or electrostatic separation of solid materials from solid materials or fluids, separation by high-voltage electric fields B03C; centrifuges, vortex apparatus B04; presses per se for squeezing-out liquid from liquid-containing material B30B9/02; treatment of water C02F, e.g. softening by ion-exchange C02F1/42; {arrangements of air intake cleaners in gas turbine plants F02C7/05} ; arrangements or mounting of filters in air-conditioning, air-humidification or ventilation F24F13/28)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Herein is described a cell density signaling protein and its tissue-specific lipid cofactor. Constructs, compositions and methods for isolation, purification and use of the protein and the tissue-specific lipid cofactor are described.

## Claims

### Claim 1

An isolated polypeptide that is 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or 100% identical or homologous to SEQ ID NOS:3, 4, 5, 7, 9, 12 or 13 and that binds to a tissue-specific lipid cofactor to form a cell density signaling complex.

### Claim 2 (depends on 1)

An isolated lipid cofactor that binds to an isolated polypeptide of claim 1 and becomes a cell density signaling molecule.

### Claim 3 (depends on 1, 2)

The isolated lipid cofactor of claim 2 that binds to a cell density signaling protein of claim 1, said lipid cofactor having a formula C63H123N2O11P and a mass of about 1114.89 MW or functional variants thereof.

### Claim 4 (depends on 3)

The isolated lipid cofactor for a cell density signaling protein of claim 3 comprising the structure of the molecule shown in FIG. 9.

### Claim 5 (depends on 2)

The isolated lipid cofactor of claim 2, said lipid cofactor having a mass of about 1114.89 MW and containing a ceramide phosphate, a single chained glycerol lipid and a linker.

### Claim 6 (depends on 5)

The isolated lipid cofactor of claim 5 wherein the lipid cofactor having a structure comprising the molecule shown in FIG. 12.

### Claim 7 (depends on 1, 3, 5)

The isolated lipid cofactor of claim 3 or 5 that has been shortened, lengthened or modified but still retains the property of binding to the protein of claim 1 and acting to signal other cells to proliferate, differentiate, or apoptose.

### Claim 8 (depends on 1)

A cell density signaling molecular complex comprising an isolated polypeptide of claim 1 bound to a lipid cofactor for cell density signaling.

### Claim 9 (depends on 1)

The polypeptide of claim 1 binds a lipid and becomes a diffusible signaling molecule.

### Claim 10

A functionally homologous isolated and purified polypeptide comprising an amino acid sequence set forth in sequence (SEQ ID NO: 5 or 13) wherein said amino acid sequence is a cell density signal protein which binds specific lipids and these molecules stimulate cellular proliferation, differentiation, and apoptosis.

### Claim 11 (depends on 10)

A protein/lipid molecule of claim 10 that regulates the proliferation and differentiation and apoptosis in cells from connective tissue.

### Claim 12 (depends on 10)

The protein of claim 10 which binds to a cell density signal, lipid co-factor.

### Claim 13 (depends on 10)

The protein of claim 10 wherein the cell density signal, lipid co-factor having a structure shown in FIG. 9 or 12.

### Claim 14

A recombinant cell density signal protein being 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or 100% identical or homologous to SEQ ID NOS:3, 4, 5, 7, 9, 12 or 13 that can still bind a lipid cofactor.

### Claim 15 (depends on 1)

An isolated polynucleotide which expresses a cell density signaling protein of claim 1 that is 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 96%, 97%, 98%, 99% or 100% identical or homologous to SEQ ID NOS:3, 4, 5, 7, 9, 12 or 13.

### Claim 16 (depends on 14)

The isolated polynucleotide of claim 14 having a sequence comprising SEQ ID NO: 6 or SEQ ID NO:14 or a fragment or variants thereof.

### Claim 17 (depends on 15)

The isolated polynucleotide of claim 15 further comprising a start codon on the N-terminus, and purification tags.

### Claim 18 (depends on 15, 16, 17)

A vector comprising an isolated polynucleotide of claim 15, 16 or 17.

### Claim 19 (depends on 18)

An expression cassette incorporating the vector of claim 18.

### Claim 20 (depends on 19)

A cell incorporating or containing the expression cassette of claim 19.

### Claim 21 (depends on 20)

The cell of claim 20 from a tissue selected from the group consisting of: bone, tendon, muscle, epithelial, epidermal, breast, cartilage and secretory glands.

### Claim 22 (depends on 20)

The cell of claim 20, wherein the tissue is from human, horse, dog or cat.

### Claim 23 (depends on 14, 15, 20)

A host cell incorporating or containing the expression cassette of claim 20 to recombinantly express the polynucleotide of claim 14 or 15.

### Claim 24 (depends on 1)

An antibody, polyclonal or monoclonal, to the protein in claim 1 used to identify and purify new lipid/protein complexes using immunodetection and immunoprecipitation.

### Claim 25 (depends on 8)

A method of purification of the lipid cofactor from the protein factor using ultrafilters and changes in salt concentration comprising the steps of:
a) filtering the conditioned medium containing the protein/lipid complex of claim 8 through a 0.2 micron filter and then raising the salt concentration by adding approximately 1/10th volume of 5M NaCl;
b) concentrating this high salt conditioned medium to about a 1 ml retentate using an ultrafilter in a stirred cell using pressurized nitrogen;
c) diluting the retentate to about 10 ml with water and reconcentrating to about 0.5 ml;
d) capturing the free protein factor in the retentate;
e) capturing the free lipid cofactor in the filtrate.
